KCRI: Clinical Trials

9 trials sponsored by KCRI, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated, 1 active not recruiting, 1 recruiting. 9 Phase 2, 5 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 29Completed 4, Terminated 2, Active not recruiting 1, Recruiting 1, Unknown 1
Phase 35Completed 3, Terminated 1, Unknown 1
Phase 11Completed 1

Follow KCRI: new trials by email

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases
MesoCellA-Ortho administration, HA administration - Osteoarthritis of Knee
Phase 1 / Phase 2CompletedJagiellonian University1922022-01-052024-03-21
Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes
Cladribine - Acute Myeloid Leukemia Myelodysplastic Syndromes
Phase 2Active not recruitingMaria Sklodowska-Curie National Research Institute of Oncology402021-10-072025-04-24
Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 "OVERALL"
Obinutuzumab, Rituximab - CD20-positive Acute Lymphoblastic Leukemia
Phase 2TerminatedMaria Sklodowska-Curie National Research Institute of Oncology492021-10-052026-11-17
Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment
Opdivo - Nasopharyngeal Cancer
Phase 2RecruitingMaria Sklodowska-Curie National Research Institute of Oncology322021-08-262026-10-20
Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI)
CardioCell, Placebos - Critical Limb Ischemia
Phase 2 / Phase 3UnknownJohn Paul II Hospital, Krakow502018-04-192021-04-09
Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)
CardioCell, Placebos - Heart Failure
Phase 2 / Phase 3CompletedJohn Paul II Hospital, Krakow1152018-04-192021-04-09
Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI)
Cardiac Drug, Placebos - Myocardial Infarction
Phase 2 / Phase 3CompletedJohn Paul II Hospital, Krakow1052017-10-202021-04-09
A Clinical Evaluation of the ProNOVA XR Polymer Free Drug Eluting Coronary Stent System
Drug Eluting Stent implantation - Myocardial Ischemia
Phase 2 / Phase 3CompletedKCRI502008-11-012011-01-20
ThromboAblation in Acute Myocardial Infarction
Laser Thromboablation, PTCA (Direct Stenting) - ST Elevation Acute Myocardial Infarction
Phase 2 / Phase 3TerminatedKCRI782008-03-012011-01-20

Conditions studied

Chronic Limb-Threatening Ischemia (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Heart Failure (1)  ·  Myocardial Infarction (1)  ·  Myocardial Ischemia (1)  ·  Nasopharyngeal Neoplasms (1)  ·  Obesity (1)  ·  Osteoarthritis (1)  ·  Osteoarthritis, Knee (1)  ·  ST Elevation Myocardial Infarction (1)  ·  Thrombosis (1)

Interventions

Cardiovascular Agents (1)  ·  Cladribine (1)  ·  Nivolumab (1)  ·  Rituximab (1)  ·  obinutuzumab (1)

Countries

Poland (9)

Top investigators

Dariusz Dudek, MD, PhD (2)  ·  Krzysztof Ficek, Prof., MD, PhD, DSc (1)

NIH funding

2019 (1)